Titre :
  • Phase II study of vinorelbine in patients with androgen-independent prostate cancer.
Auteur : Oudard, S ; Caty, A ; Humblet, Yves ; Beauduin, Marc ; Suc, E ; Piccart-Gebhart, Martine ; Rolland, Frédéric ; Fumoleau, Pierre ; Bugat, Roland ; Houyau, P ; Monnier, A ; Sun, X ; Montcuquet, P ; Breza, J ; Novak, J ; Gil, Thierry ; Chopin, D
Informations sur la publication : Annals of oncology, 12, 6, (page 847-852)
Statut de publication : Publié, 2001-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adenocarcinoma -- drug therapy
Adenocarcinoma -- pathology
Aged
Aged, 80 and over
Androgens -- metabolism
Antineoplastic Agents, Phytogenic -- administration & dosage
Antineoplastic Agents, Phytogenic -- therapeutic use
Antineoplastic Agents, Phytogenic -- toxicity
Disease-Free Survival
Drug Administration Schedule
Humans
Leukopenia -- chemically induced
Male
Middle Aged
Neoplasm Metastasis
Neutropenia -- chemically induced
Pain Measurement
Prostate-Specific Antigen -- blood
Prostatic Neoplasms -- drug therapy
Prostatic Neoplasms -- pathology
Quality of Life
Vinblastine -- administration & dosage
Vinblastine -- adverse effects
Vinblastine -- analogs & derivatives
Vinblastine -- therapeutic use
Note : Clinical Trial
Clinical Trial, Phase II
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/11484963